Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes.
about
Risk of second cancers in survivors of prolymphocytic leukemia: a SEER data analysis.Radioimmunotherapy consolidation using 131I-tositumomab for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in first remission.The various aspects of genetic and epigenetic toxicology: testing methods and clinical applicationsIbrutinib as Initial Therapy for Patients with Chronic Lymphocytic LeukemiaMolecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma.B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib.Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemiaA review of supportive care and recommended preventive approaches for patients with chronic lymphocytic leukemia.Chronic lymphocytic leukemia (CLL)-Then and now.Targeted Therapy in Chronic Lymphocytic Leukemia (CLL).Profile of venetoclax and its potential in the context of treatment of relapsed or refractory chronic lymphocytic leukemia.Recent therapeutic advances in chronic lymphocytic leukemia.Experience with ibrutinib for first-line use in patients with chronic lymphocytic leukemia.Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL.The potential combination of BCL-2 inhibitors and ibrutinib as frontline therapy in chronic lymphocytic leukemia.Novel agents versus chemotherapy as frontline treatment of CLL.Pharmacokinetic and pharmacodynamic evaluation of ibrutinib for the treatment of chronic lymphocytic leukemia: rationale for lower doses.Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytes.Age-related clonal hematopoiesis and monoclonal B-cell lymphocytosis/chronic lymphocytic leukemia: a new association?Leukoerythroblastosis with Cytopenia as an Initial Presentation of Lung Adenocarcinoma
P2860
Q31147302-6225098D-4E37-42ED-9ADB-B251522E6AE8Q33424056-5D84B61C-A88C-4E8D-9962-FC40D411DF4CQ33716668-882B28A8-9636-4939-8D88-2FE5ADDA17F8Q36490049-7B54B96B-A6FC-4A9F-98F1-B57BB469B88DQ36550468-6BED42A6-3B8E-4F60-A581-17079179BB42Q36689790-BEC84027-A0E6-4121-A840-3BF93CC51585Q36726837-F0234E22-3BEF-4B39-A887-D1B6F505BC15Q36935200-9EF93AEF-E9C1-4CC6-B251-B43B7B2A80BCQ38664705-B7790AD4-D02C-4104-A17B-035AABD334E9Q38675358-BBDC2ACB-DF2A-419E-9D04-2791D0784902Q38982682-B611E892-E9B4-480A-BA4B-E730F0055C91Q39145934-7C49EA6F-DFCF-4112-B1A1-430639BA4A15Q46318389-3B5863A7-82D2-45CE-B9E2-96C29D28FBDCQ47424531-23BFC6E2-3ECC-480B-82A9-5C87FB6BAEB5Q48310393-9FFBEEF4-63A6-416F-9ECF-0D341ACBEA41Q51014811-90DA65E3-36F5-41E8-B389-6535ED0D79D0Q53454991-BA0ECD41-5DEC-42DD-A383-10D54B8DD43DQ53963822-AEBA411F-7FE9-4F51-BF80-4FCDDFBBF292Q55312558-C67BD914-D213-4F39-B5AB-5B5246A340D6Q55400468-05FFCBE8-69C7-4A44-AE98-07D6272C87B0Q58768124-D5B2F4E9-3D79-4FEC-92CB-88F69231A299
P2860
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Second cancers in patients wit ...... ibution and clinical outcomes.
@ast
Second cancers in patients wit ...... ibution and clinical outcomes.
@en
type
label
Second cancers in patients wit ...... ibution and clinical outcomes.
@ast
Second cancers in patients wit ...... ibution and clinical outcomes.
@en
prefLabel
Second cancers in patients wit ...... ibution and clinical outcomes.
@ast
Second cancers in patients wit ...... ibution and clinical outcomes.
@en
P2093
P2860
P50
P1433
P1476
Second cancers in patients wit ...... ibution and clinical outcomes.
@en
P2093
Jan Burger
Long Trinh
Ohad Benjamini
Preetesh Jain
Sara S Strom
Xuemei Wang
P2860
P304
P356
10.3109/10428194.2014.957203
P50
P577
2014-11-19T00:00:00Z